Lonza | LONN - Operating Profit

Stock Price
488.60
Daily Change
8.80 1.83%
Monthly
-1.97%
Yearly
-15.85%
Q2 Forecast
470.40

Lonza reported CHF673M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Akzo Nobel EUR 254M 37M Mar/2026
Alcon AG USD 313M 19M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Demant DKK 2.09B 224M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Geberit CHF 134.1M 65.8M Dec/2025
Genmab DKK 260M 199M Dec/2025
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 142M 89M Dec/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Sika AG CHF 724.9M 73.2M Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Solvay EUR 60M 78M Dec/2025
UCB EUR 1.29B 571M Dec/2025